Panagora Asset Management’s CareDx CDNA Stock Holding History
Bought
Maintained
Sold
Other funds holding CDNA
AIM
FAM
ACH
BG
Panagora Asset Management's CDNA Position: Q2 2022 in Review
Panagora Asset Management sold out of CareDx (CDNA) in Q2 2022, closing a stake of 10,537 shares — an estimated $390K sold.
Panagora Asset Management first reported a position in CDNA in Q1 2017 and held it in 17 quarters. The position peaked at $555K in Q2 2021. 184 funds tracked by Wall St. Rank hold CDNA as of Q2 2022.
- Panagora Asset Management reported no remaining CareDx position as of Q2 2022 after selling out during the quarter.
- Panagora Asset Management sold 10,537 CareDx shares in Q2 2022, an estimated $390K.
- Panagora Asset Management first reported a position in CareDx in Q1 2017 and held it in 17 quarters.
- Panagora Asset Management's CareDx position peaked at $555K in Q2 2021.
- 184 funds tracked by Wall St. Rank held CareDx as of Q2 2022.
Based on Panagora Asset Management's 13F filing for Q2 2022, filed 15 Aug 2022.